MarketInOut Stock Screener Log In | Sign Up

Vivimed Labs Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 14:20
Vivimed Labs Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization504.95 mln
Float50.00 mln

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-5.74
Highly reliable

Relative Strength

4 / 100
Severely lagging

Pre-Tax Margin

-252%
Severely loss-making

ROE

207
Extraordinary

Altman Z-Score

-0.11
Deeply distressed

Business Description

Founded in 1988 and headquartered in Hyderabad, India, Vivimed Labs Limited produces and sells a broad range of pharmaceutical and chemical products both domestically and internationally. Its pharmaceutical arm supplies raw drug ingredients and intermediate compounds to generic medicine makers, while also offering finished medicines across areas such as eye care, skin treatment, pain relief, and nutrition. The company additionally manufactures products on behalf of other businesses, covering tablets, capsules, liquids, sprays, and ointments. A separate division focuses on specialty chemicals sold under its own retail brands.

Key Fundamentals

EPS-21.13
ROE207
RPS9.15
ROIC-18.72
ROA-20.38
Interest Cover-42.68
EBITDA, mln-1,461
EV / EBITDA-3.02
EV / EBIT-2.56
Revenue, mln700
EV / Revenue6.30

Quote Details

Last 5.75
Change -0.11 (-1.88%)
Open 5.75
Volume 348
Turnover 2,001
Average Volume 79,700

Financial Ratios

Pre-Tax Profit Margin-252
Current Ratio0.38
Price / Cash Flow6.56
Price / Free Cash Flow17.12
Price / Sales0.64

Financial Strength

Altman Z-Score-0.11
Piotroski F-Score 3 / 9
Beneish M-Score-5.74
Price to Intrinsic Value0.26

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -9.16% 7 / 100   
1 Month 3.6% 90 / 100   
2 Months 12.52% 86 / 100   
6 Months -16.42% 32 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog